Who is Brian Higgins?
Brian Higgins was a Democratic U.S. Representative from New York's 26th congressional district (Buffalo/Niagara Falls area), serving from 2005 until his resignation in February 2024 when he left Congress to become president and CEO of Highmark Health, a Pittsburgh-based health insurance organization.
During his time in Congress, Higgins served on the House Budget Committee and the House Ways and Means Committee — one of the most powerful tax-writing committees in the House, with jurisdiction over trade, tax policy, Social Security, Medicare, and health programs. His Ways and Means role created particular policy overlap with healthcare and financial sector stocks.
Most Traded Stocks
Based on all STOCK Act filings in Capitol Trader's database, Brian Higgins has traded these stocks most frequently:
Net buying activity has been heaviest in NVDA. Net selling has been most notable in ANY.
Trading Pattern Analysis
Higgins was among the more active House traders during his tenure, with a portfolio that reflected the broad market exposure of a professionally managed account. His Ways and Means Committee role gave him jurisdiction over tax legislation, trade agreements, and healthcare reimbursement policy — areas that directly affect companies across multiple sectors.
His departure from Congress in early 2024 to join Highmark Health — a healthcare company — illustrates the revolving door dynamic that many critics of congressional trading argue creates compounding conflicts of interest when members hold healthcare stocks while overseeing healthcare policy.
Recent Disclosed Trades
The six most recent STOCK Act disclosures filed by Brian Higgins:
Showing 6 most recent. View all 2 trades →
How to Interpret These Disclosures
All trade data shown here comes from official STOCK Act filings. Using this public government data for investment research is entirely legal — the STOCK Act was designed precisely to give citizens visibility into congressional trading activity.
Key limitations to keep in mind: the STOCK Act allows up to 45 days between a transaction and its public disclosure. By the time you see a filing, any information advantage that may have existed at the time of the trade has likely been incorporated into market prices.
Trade amounts are disclosed as ranges, not exact figures. For example, a filing showing "$50,001 – $100,000" means the actual amount could be anywhere in that bracket. This limits precision in dollar-value analysis.
Research these stocks
Affiliate link — Capitol Trader may earn a commission at no cost to you.